The successful application of the Arndt‐Eistert protocol starting from commercially available N‐{[(9H‐fluoren‐9‐yl)methoxy]carbonyl}‐protected (Fmoc) α‐amino acids leading to enantiomerically pure N‐Fmoc‐protected β‐amino acids in only two steps and with high yield is reported.
No takes yet. Share an insight, caveat, or question.
Ellmerer‐Müller et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: